首页> 外文期刊>International Journal of Cardiology >Response to 'Letter to the Editor concerning: 'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants''

【24h】

Response to 'Letter to the Editor concerning: 'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants''

机译：对“关于编辑的信”的回应：非血管性颤动患者的网络元分析系统审查：用直接口服抗凝剂治疗后疗效和安全性的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Cardiology》 |2020年第2020期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献

1. Response to "Letter to the Editor concerning: 'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants'" [J] . International Journal of Cardiology . 2020,第期

机译：对“关于编辑的信”的回应：非血管性颤动患者的网络元分析系统审查：用直接口服抗凝剂治疗后疗效和安全性的比较
2. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score???2: [J] . Maria M Fernandez, Jianmin Wang, Xin Ye, Sage Open Medicine . 2015,第4期

机译：系统评价和网络荟萃分析在非瓣膜性心房颤动和CHADS2评分中使用依多沙班与其他非维生素K拮抗剂口服抗凝剂的相对疗效和安全性??? 2：
3. Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials" [J] . de Veer Anne J. W. M., Bennaghmouch Naoual, Mahmoodi Bakhtawar K., Circulation: An Official Journal of the American Heart Association . 2018,第12期

机译：De Veer等人对文章的回应，“使用非维生素K拮抗剂口腔抗凝血剂的疗效和伴随阿司匹林疗法患者的疗效和安全性：随机试验的荟萃分析”
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Optimal Post-Procedural Therapy for Patients Ineligble for Treatment with Oral Anticoagulatiion Who Undergo Left Atrial Appendage Occlusion with the Watchman Device for Non-Valvular Atrial Fibrillation [D] . Whitehead, Kristen Marie. 2020

机译：用口腔抗凝血治疗患者患者的最佳过程治疗患者患有左心房阑尾闭塞与鹰刀用于非瓣膜心房颤动
6. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score ⩾ 2 [O] . Maria M Fernandez, Jianmin Wang, Xin Ye, 2015

机译：系统评价和网络荟萃分析在非瓣膜性房颤和CHADS2评分⩾2患者中使用依多沙班与其他非维生素K拮抗剂口服抗凝剂的相对疗效和安全性
7. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score ⩾ 2 [O] . Maria M Fernandez, Jianmin Wang, Xin Ye, 2015

机译：非瓣膜性心房颤动和CHaDs2评分为2的edoxaban与其他非维生素K拮抗剂口服抗凝剂的相对疗效和安全性的系统评价和网络荟萃分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号